An Open-Label Prospective Proof-Of-Concept Trial to Evaluate the Response to Acthar Gel Therapy in Patients With Multiple Sclerosis (MS) Relapses Who Have Failed To Make an Adequate Recovery After Treatment With High-Dose Intravenous Methylprednisolone
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Jun 2017.
- 15 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.
- 22 Mar 2016 Planned primary completion date changed from 1 Jul 2014 to 1 Nov 2016 as per ClinicalTrials.gov record.